How Can Data Science Accelerate Drug Discovery Processes?

In this contributed article, April Miller, senior IT and cybersecurity writer for ReHack Magazine, describes how thoughtfully applied data science principles and tools empower modern researchers to find new, viable treatment methods for various diseases and ailments. Humans will always be essential to drug discoveries, but the fascinating examples here and elsewhere show the power of using purposeful data analytics to meet shared goals. 

AI Startup Jivi’s LLM Beats OpenAI’s GPT-4 & Google’s Med-PaLM 2 in Answering Medical Questions 

A purpose-built medical LLM developed by Jivi, an Indian startup co-founded by former BharatPe Chief Product Officer Ankur Jain, has claimed the number one slot on the Open Medical LLM Leaderboard. 

From the Office to the Shop Floor – the Impact of AI-powered Technologies in the Supply Chain Industry

In this contributed article, Andrei Danescu, Co-Founder & CEO of robotics and data intelligence company, Dexory, suggests that it is no surprise that AI has found its place in various industries from finance and healthcare related industries, all the way to manufacturing and supply chains. Its seamless integration with existing technologies is driving the widespread adoption we are witnessing today.

FinTech Studios® Launches Apollo PRO® and RegLens PRO® Market Intelligence and Regulatory Intelligence Apps Powered with Conversational Generative AI 

FinTech Studios Inc., a leading Gen AI platform for enterprise search, market intelligence and regulatory intelligence, announced Apollo PRO and RegLens PRO, the most advanced generative AI enterprise search, market intelligence and regulatory intelligence apps that includes a “conversational chat” interface and contextually relevant “suggested prompts”, seamlessly integrated with millions of authoritative sources of web and enterprise content.

Where Artificial Intelligence Is Making a Difference in Healthcare

In this contributed article, Rajesh Viswanathan, Chief Technology Officer for Inovalon, discusses how for the past year, AI was at the center of conversations throughout healthcare. While the potential for AI to revolutionize healthcare is clear, from care delivery to enhancing operational efficiencies and accelerating research, many organizations are still figuring out where to begin.

Counteracting Financial Crimes with Generative Models 

In this contributed article, editorial consultant Jelani Harper discusses generative models, synthetic data, and combating financial crimes. Generative models are gradually reshaping the nature of financial crimes. They can help and hinder both investigators and the fraudsters perpetuating criminal activity.

Video Highlights: The Best AI Startup Opportunities — with Venture Capitalist Rudina Seseri

In this video presentation, our good friend Jon Krohn, Co-Founder and Chief Data Scientist at the machine learning company Nebula, sits down with Rudina Seseri from Glasswing Ventures to answer the question: “What has Glasswing Ventures done for the company beyond capital investment?” Rudina describes how her company uses data to assess venture capital investments, the secret sauce of successful AI startups, and why she feels generative AI is only the start of a much broader impact that AI will make in communities and businesses.

Hitachi Vantara Announces Collaboration with NVIDIA to Create New Portfolio of Industrial AI Solutions

Hitachi Vantara, the data storage, infrastructure, and hybrid cloud management subsidiary of Hitachi, Ltd. (TSE: 6501), today announced a collaboration with NVIDIA to create a new generation of transformational artificial intelligence (AI) solutions. Hitachi Vantara will develop a portfolio of solutions, Hitachi iQ, to drive targeted AI outcomes by layering industry-specific capabilities on top of its AI solution stack, so outcomes can be more specific and relevant to an organization’s business. 

Quantum-Enhanced Generative AI Generates Viable Cancer Drug Candidates

Zapata Computing, Inc., the Industrial Generative AI company, announced that its scientists, in collaboration with Insilico Medicine, the University of Toronto, and St. Jude Children’s Research Hospital have demonstrated the first instance of a generative model running on quantum hardware outperforming state-of-the-art classical models in generating viable cancer drug candidates. The research points to a promising future of hybrid quantum generative AI for drug discovery using today’s quantum devices.

Using Clinician Big Data to Alleviate a Struggling Workforce

In this contributed article, Charlie Lougheed, CEO and co-founder of Axuall, explains why healthcare needs to adjust its thinking and in what ways clinician big data can make impactful changes throughout the healthcare industry, from credentialing to attrition.